Last reviewed · How we verify

NCT02828787: PRURIM

Central Mechanisms of Chronic Pruritus: Functional and Structural Brain Imaging.

Terminated NA Last updated 5 November 2020
What this trial tests

NA trial testing MRI in Itch in 31 participants. Terminated before completion.

Timeline
16 January 2017
Primary endpoint
31 May 2018
31 May 2018

Quick facts

Lead sponsorUniversity Hospital, Brest
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment31
Start date16 January 2017
Primary completion31 May 2018
Estimated completion31 May 2018
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Itch. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to identify by functional and structural MRI which are the brain areas activated in various pruritic situations to deduct a model describing the different causes of pruritus. The investigators are going to compare two chronic pruritus conditions (histaminergic urticaria and non histaminergic: psoriasis) to a healthy control group. The secondary objective of this study is to specify a classification index from the physiological results obtained by brain imaging to differentiate multiple types of pruritus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

Other recruiting trials for Itch

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02828787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing